Briefly Bio

London, United Kingdom

Briefly Bio is a biotech platform that provides a solution to make lab work reproducible.

$1.2M raised

Jul 2024

Pre-Seed

Top Investors

CompoundNP-Hard VenturesTiny VC

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Briefly Bio raised?

Briefly Bio has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2024.

Who are Briefly Bio's investors?

Briefly Bio's investors include Compound, NP-Hard Ventures, Tiny VC.

Where is Briefly Bio headquartered?

Briefly Bio is headquartered in London, United Kingdom.

What does Briefly Bio do?

Briefly Bio is a biotech platform that provides a solution to make lab work reproducible.

What stage is Briefly Bio at?

Briefly Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 17, 2024.

MLA

"Briefly Bio — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/briefly-bio. Accessed June 17, 2026.

APA

VCBacked. (2024). Briefly Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/briefly-bio

Wikipedia (cite web)

{{cite web |title=Briefly Bio — Funding & Investors |url=https://www.vcbacked.co/company/briefly-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 17, 2024.